Business News

The outbreak of the corona virus exhibits indicators of slowing down in Arizona, Texas and Florida

A healthcare worker collects samples with a nasal swab on July 24, 2020 in a mobile COVID-19 test facility in Miami Beach, Florida, USA.

Anadolu agency | Anadolu agency | Getty Images

Coronavirus outbreaks in Arizona, Florida, and Texas appear to be slowing as more people practice social distancing and states are stopping plans from reopening.

On Sunday, Arizona reported a 13% drop in the seven-day average of new Covid 19 cases, with 2,627 newly diagnosed cases in the last 24 hours, up from 3,022 a week earlier. This emerges from a CNBC analysis of the data compiled by Johns Hopkins University.

The state has also seen signs that its hospital stays at Covid-19 may slow down. This comes from data compiled by the Covid Tracking Project, a volunteer group founded by journalists from The Atlantic magazine. As of Sunday, hospitalizations with coronaviruses also decreased by around 14% compared to the previous week to a 7-day average of 2,919.

Cases in Texas dropped nearly 19% last week and, according to CNBC analysis, reached around 8,404 new cases a day on Sunday, based on a seven-day moving average on Sunday. The highest average daily new cases on July 20 was 10,572. CNBC uses a seven-day average to calculate the Covid 19 trends because it compensates for inconsistencies and gaps in the condition data.

Although Texas shows signs of new infections slowly slowing, it hit a record high on Sunday with an average hospital stay of 10,840 Covid-19 patients. On the same day, the state also broke a bleak record of an average of 152 newborns a day.

According to Johns Hopkins, Florida has just started to flatten out since it hit a record 11,870 new cases every day on July 17. The state had an average of 10,544 new cases on Sunday, which corresponds to a decrease of 8% compared to the previous week.

However, the state is still reporting an increase in hospital stays and deaths as the virus continues to affect densely populated cities in South Florida.

US Secretary of Health and Human Services Alex Azar said Monday that officials in severely affected states are beginning to see cases flattening out as people "step on the table."

"It's because people actually wear masks. They wear their masks. They are socially distant. They rely on good personal hygiene," Azar told Fox and Friends.

Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration, also said Monday that hot spots in the US Sunbelt region are gradually plateauing in terms of the number of new Covid 19 cases.

"Overall, it looks like Arizona, Texas, and probably Florida at least are reaching a plateau," he said in "Squawk Box." "Arizona looks like they're slowly going down the epidemic curve. I think this will be extensive plateaus. I think we're going to hang around at the level of infection we're at."

However, Gottlieb warned: "Even if these states fall, other states will look as if they are warming up, and so they will start to offset the profits that we make in the sun belt."

For the first time since June 12, the growth rate of average daily new Covid 19 cases in the US fell on Sunday compared to a week ago. Nationwide, there were an average of 65,809 new cases per day on Sunday, a decrease of 1.6% compared to the previous week, based on a moving average of seven days.

While the number of new coronavirus cases in the United States has decreased in the past few days, it does not provide an accurate picture of the infection rate. Weekend reports from states tend to be delayed as some districts only publish their numbers on weekdays.

Gottlieb also said that some states have not reported their numbers reliably since the Ministry of Health and Human Services has instructed all hospitals to stop reporting their data to the long-standing national health network of the Centers for Disease Control and Prevention. Instead, hospitals now have to report to HHS through a new portal that went live a week ago.

Disclosure: Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, the start-up company for genetic testing Tempus and the biotech company Illumina.

Related Articles